In this issue:
Supporting individualised care for advanced cancer
Vinorelbine + trastuzumab favoured in HER2-positive advanced disease
The influence of insulin resistance on breast cancer progression
Iniparib in metastatic triple-negative breast cancer
Can the USC Van Nuys Prognostic Index predict recurrence and death?
Tamoxifen and radiotherapy for DCIS: benefits compared
Dose-dense chemotherapy in non-metastatic breast cancer
Occult metastases in breast cancer
Mammograms beneficial in ages 40–49 years
Please login below to download this issue (PDF)